Biotech Goes Sky-High After LSD Drug Treats Depression
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Biotech Goes Sky-High After LSD Drug Treats Depression" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Yahoo Finance, Fierce Biotech, Business Wire and Reuters. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 95d ago.
Quick answers
Why is "Biotech Goes Sky-High After LSD Drug Treats Depression" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (5)
- DFTX Stock Rallies Ahead Of High-Stakes Phase 3 Depression Drug Trial Results Yahoo Finance · 97d ago
- Definium’s LSD formula produces ‘best data ever seen’ in a pivotal depression trial, CEO says Fierce Biotech · 97d ago
- Definium Therapeutics to Discuss Topline Results from Phase 3 Emerge Study in Major Depressive Disorder on June 22, 2026 Business Wire · 97d ago
- Definium's LSD-based depression pill delivers strong late-stage results, shares surge Reuters · 97d ago
- Biotech Goes Sky-High After LSD Drug Treats Depression Investor's Business Daily · 97d ago
Topics
Related trends
AI co-scientists are revolutionizing how research is done
AI co-scientists and teams of thousands of autonomous agents are reshaping biomedical research and drug discovery.
Biotech's most exciting startups of 2026: Meet this year's Endpoints 11
Endpoints News announces its 2026 Endpoints 11 Awards, highlighting biotech startups including K2 Therapeutics and Corsera Health.
US 30-Year Yield Tops 5.5% in ‘Vacuum’ After Sentiment Gauge
US 30-year bond yields top 5.5% following a sentiment gauge, as reported by Bloomberg.com.
Novo Nordisk to Pay Up to $1.3 Billion for Nanexa’s Drug Delivery Technology
Novo Nordisk strikes a $1.3 billion deal with Nanexa to secure long-acting obesity injection technology.
Pancreatic Cancer Disappears in Mice After New mRNA Immunotherapy
Recent studies detail an mRNA immunotherapy strategy that reportedly leads to pancreatic cancer disappearing in mice.
6 People Are Missing After Explosion in Athens Tourist District
Six people are reported dead after a building explosion near the Acropolis in the Plaka district of Athens, Greece.